Prosecution Insights
Prosecution Insights
19 pending office actions • 13 art units • 18 examiners • 0 of 19 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (5%) |
| §103 only | 5 (26%) |
| §112 only | 1 (5%) |
| Double-patenting only | 3 (16%) |
| Double-patenting + other | 3 (16%) |
| Multi-statute (no §101) | 5 (26%) |
| No statute on record | 1 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LARA, CAROLINE MONSERRAT | 2 | 100.0% | +0.0% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.0% | +16.2% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 53.4% | +40.2% |
| WERTZ, ASHLEE ELIZABETH | 1 | 51.1% | +39.8% |
| RYAN, DOUGLAS CHARLES | 1 | 40.3% | +50.7% |
| SIFFORD, JEFFREY MARK | 1 | 55.7% | +32.1% |
| BROWN, MINDY G | 1 | 52.4% | +47.5% |
| CREWS, JARET JAMES | 1 | 43.5% | +73.8% |
| CHESTNUT, BARRY A | 1 | 73.4% | +6.3% |
| PAK, YONG D | 1 | 74.6% | +14.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925125 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF USING THE SAME FOR TREATING COVID-19 | LARA, CAROLINE MONSERRAT | 22d overdue |
| 17925114 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION | LARA, CAROLINE MONSERRAT | 16d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18161857 | METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS | GREENE, IVAN A | 45d overdue |
| 18284177 | PURIFICATION AND RECYCLING OF mRNA NUCLEOTIDE CAPS | CREWS, JARET JAMES | 30d overdue |
| 18008139 | BACTERIAL STRAINS FOR DNA PRODUCTION | TINSLEY, BRENDAN THOMAS | 1d overdue |
| 18569776 | CORONAVIRUS GLYCOSYLATION VARIANT VACCINES | SIFFORD, JEFFREY MARK | — |
| 18284938 | METHODS FOR IDENTIFICATION AND RATIO DETERMINATION OF RNA SPECIES IN MULTIVALENT RNA COMPOSITIONS | BROWN, MINDY G | — |
| 18272512 | VARIANT STRAIN-BASED CORONAVIRUS VACCINES | CHEN, STACY BROWN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284177 | PURIFICATION AND RECYCLING OF mRNA NUCLEOTIDE CAPS | CREWS, JARET JAMES | 30d overdue |
| 18291707 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS | WERTZ, ASHLEE ELIZABETH | 34d |
| 17928680 | PHENYLALANINE HYDROXYLASE VARIANTS AND USES THEREOF | PAK, YONG D | 75d |
| 19410723 | BETACORONAVIRUS mRNA VACCINES | KINSEY WHITE, NICOLE ERIN | — |
| 18709314 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | ABBAS, ABDULRAHMAN MUSTAFA | — |
| 18578052 | POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA | RYAN, DOUGLAS CHARLES | — |
| 18569776 | CORONAVIRUS GLYCOSYLATION VARIANT VACCINES | SIFFORD, JEFFREY MARK | — |
| 18284938 | METHODS FOR IDENTIFICATION AND RATIO DETERMINATION OF RNA SPECIES IN MULTIVALENT RNA COMPOSITIONS | BROWN, MINDY G | — |
| Art Unit | Apps |
|---|---|
| 1672 | 3 |
| 1612 | 3 |
| 1633 | 2 |
| 1671 | 1 |
| 1683 | 1 |
| 1691 | 1 |
| 1652 | 1 |
| 1631 | 1 |
| 1615 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19410723 | BETACORONAVIRUS mRNA VACCINES | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Final Rejection | — | Pending | Dec 05, 2025 |
| 18709314 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103§112DP | Non-Final OA | — | Pending | May 10, 2024 |
| 18291707 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS | WERTZ, ASHLEE ELIZABETH | 1612 | DP | Final Rejection | 34d | Pending | Jan 24, 2024 |
| 18578052 | POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA | RYAN, DOUGLAS CHARLES | — | DP | Non-Final OA | — | Pending | Jan 10, 2024 |
| 18569776 | CORONAVIRUS GLYCOSYLATION VARIANT VACCINES | SIFFORD, JEFFREY MARK | 1671 | §102§103§112Other | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18284938 | METHODS FOR IDENTIFICATION AND RATIO DETERMINATION OF RNA SPECIES IN MULTIVALENT RNA COMPOSITIONS | BROWN, MINDY G | 1683 | §102§103§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18284177 | PURIFICATION AND RECYCLING OF mRNA NUCLEOTIDE CAPS | CREWS, JARET JAMES | 1691 | §103§112 | Non-Final OA | 30d overdue | Pending | Sep 26, 2023 |
| 18282097 | THERAPEUTIC USE OF SARS-COV-2 MRNA DOMAIN VACCINES | CHESTNUT, BARRY A | 1672 | §103 | Non-Final OA | 17d overdue | Pending | Sep 14, 2023 |
| 17928680 | PHENYLALANINE HYDROXYLASE VARIANTS AND USES THEREOF | PAK, YONG D | 1652 | §102§103DPOther | Final Rejection | 75d | Pending | Jul 18, 2023 |
| 18272512 | VARIANT STRAIN-BASED CORONAVIRUS VACCINES | CHEN, STACY BROWN | 1672 | §101 | Non-Final OA | — | Pending | Jul 14, 2023 |
| 18177455 | MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS | LEONARD, ARTHUR S | 1631 | §103§112DPOther | Non-Final OA | — | Pending | Mar 02, 2023 |
| 18040745 | METHODS OF PREPARING LIPID NANOPARTICLES | SHOMER, ISAAC | 1612 | DP | Final Rejection | — | Pending | Feb 06, 2023 |
| 18040485 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | — | Pending | Feb 03, 2023 |
| 18161857 | METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS | GREENE, IVAN A | 1619 | §103§112 | Final Rejection | 45d overdue | Pending | Jan 30, 2023 |
| 18008139 | BACTERIAL STRAINS FOR DNA PRODUCTION | TINSLEY, BRENDAN THOMAS | 1634 | §102§103§112 | Final Rejection | 1d overdue | Pending | Dec 02, 2022 |
| 17925114 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION | LARA, CAROLINE MONSERRAT | 1633 | §103 | Final Rejection | 16d overdue | Pending | Nov 14, 2022 |
| 17925125 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF USING THE SAME FOR TREATING COVID-19 | LARA, CAROLINE MONSERRAT | 1633 | §103 | Final Rejection | 22d overdue | Pending | Nov 14, 2022 |
| 17761420 | CAP GUIDES AND METHODS OF USE THEREOF FOR RNA MAPPING | QIAN, CELINE X | 1637 | §103 | Non-Final OA | — | Pending | Mar 17, 2022 |
| 17277829 | STEROL ANALOGS AND USES THEREOF | MCDOWELL, BRIAN E | 1624 | Other | Non-Final OA | — | Pending | Mar 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial